An observational study in Cancer, sponsored by Entia Ltd. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Entia Ltd · Observational
To validate the usability and safety of the Liberty Analyser.
9,365 studies on the registry are indexed under Neoplasms; 2,489 are open to participants now.
Browse Neoplasms studies →Entia Ltd is the lead sponsor of 16 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults with a diagnosis of solid tumour cancer, who are currently undergoing systemic anti-cancer therapy
Exclusion Criteria:
Home monitoring
The Entia Liberty Analyser is easy to use
Users can easily carry out a test using the Entia Liberty Analyser
Time frame: Through study completion, 1 day
The Entia Liberty Analyser is safe to use
Results obtained using the Entia Liberty Analyser are valid and reliable
Time frame: Through study completion, 1 day
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is withdrawn, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Entia Ltd